Details of the Drug

General Information of Drug (ID: DM8C1H4)

Drug Name
PF-06823859
Indication
Disease Entry ICD 11 Status REF
Dermatomycosis EA60 Phase 2 [1]
Rheumatoid arthritis FA20 Phase 2 [2]
Lupus 4A40 Phase 1 [3]
Cross-matching ID
TTD ID
D08RDD
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interferon-beta (IFNB1) TT4TZ8J IFNB_HUMAN Blocker [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03181893) A Study In Adults With Moderate To Severe Dermatomyositis. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)